Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-10-10-Speech-4-049"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-10-10"^^xsd:date2
dcterms:Is Part Of	lp_eu:Dangerous substances and preparations (c/m/r)2
dcterms:Language	"sv"^^xsd:language2
lpv:document identification number	"en.20021010.3.4-049"2
lpv:hasSubsequent	lp_eu:2002-10-10-Speech-4-0502
lpv:speaker	lp:Inger Schörling2
lpv:spokenAs	member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (2002-02-06--2004-07-19)3 member; G/EFA (1999-07-20--2004-07-19)3 unknown; Miljöpartiet (1999-07-20--2004-07-19)3 substitute; Committee on Development and Cooperation (2002-01-17--2004-07-19)3
lpv:translated text	"Mr President, this second reading is incredibly important, since it deals with the twenty-third amendment to the directive on restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogens, mutagens or substances toxic to reproduction), the so-called CMR substances. Neither the Council nor the Commission have wanted to meet the European Parliament halfway in our demand for the directive to include products as well. After all, products are the main source of exposure for the public, for example in toys, textiles or flooring. The risk assessment carried out in accordance with the Commission’s proposal is actually based on the precautionary principle and states clearly that the safety of the public is to be guaranteed. This can only be brought about if there is also a ban on CMR substances in consumer goods. For some obscure reason, the Commission and the Council have not wanted to accept this, despite there being scientific evidence. The Council also points out that a large number of products are involved and that this is supposedly a reason for not doing anything. It should in fact be the other way round. If a large number of products contain CMR substances, we should obviously act even faster. I would have preferred to see a proposal for a ban as early as 2002, but we have not been able to get that far. It is always a pleasure to work with the gentlemanly Dr Nisticò. We have been able to produce a constructive amendment, a compromise between Dr Nisticò and fellow Members from the Group of the Party of European Socialists and the Group of the Greens/European Free Alliance. I would urge fellow Members to vote in favour of Amendment No 2. We cannot wait any longer. It is irresponsible to do so, nor is it in accordance with the precautionary principle. I appeal to fellow Members: vote in favour of Amendment No 2."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph